-+ 0.00%
-+ 0.00%
-+ 0.00%

Bayer Q2 FY26 net income swings to profit at €219 million; net sales rise 1.2% to €10.87 billion

PUBT·08/04/2026 05:33:55
Listen to the news
Bayer Q2 FY26 net income swings to profit at €219 million; net sales rise 1.2% to €10.87 billion
  • Bayer net income swung to profit of €219 million in Q2, while net sales rose 1.2% to €10.87 billion.
  • EBIT climbed to €827 million, while EBITDA before special items increased 1.9% to €2.14 billion.
  • Core earnings per share from continuing operations fell 16.7% to €0.95, while net financial debt edged up 1.1% to €33.65 billion.
  • Crop Science EBITDA before special items rose 30.2% to €902 million, while Pharmaceuticals slipped 3.6% to €1.06 billion.
  • Currency-adjusted 2026 outlook was confirmed; net financial debt forecast was cut to €29 billion-€30 billion on a planned €3 billion Apollo investment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.